REALE, ANTONIA
 Distribuzione geografica
Continente #
NA - Nord America 938
EU - Europa 158
AS - Asia 102
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.199
Nazione #
US - Stati Uniti d'America 938
CN - Cina 77
SE - Svezia 77
GB - Regno Unito 24
BE - Belgio 15
FI - Finlandia 14
SG - Singapore 10
IT - Italia 8
DE - Germania 7
IE - Irlanda 7
VN - Vietnam 7
IN - India 4
CZ - Repubblica Ceca 3
IR - Iran 3
FR - Francia 2
EU - Europa 1
IL - Israele 1
UA - Ucraina 1
Totale 1.199
Città #
Fairfield 146
Woodbridge 110
Chandler 96
Ann Arbor 86
Seattle 74
Ashburn 71
Wilmington 53
Nyköping 51
Houston 47
Cambridge 44
Beijing 19
Nanjing 19
Brussels 15
Lawrence 14
New York 14
Roxbury 14
Boardman 11
Des Moines 11
Helsinki 11
Inglewood 9
Singapore 9
Dearborn 7
Dong Ket 7
Dublin 7
Falls Church 7
Hebei 6
Los Angeles 6
Munich 6
Brooklyn 5
Jiaxing 5
San Diego 4
Ardabil 3
Brno 3
Jacksonville 3
Kunming 3
Nanchang 3
Princeton 3
Shanghai 3
Tappahannock 3
Augusta 2
Baotou 2
Changsha 2
Hefei 2
Leawood 2
London 2
Monmouth Junction 2
San Mateo 2
Bari 1
Beersheba 1
Changchun 1
Guangzhou 1
Heze 1
Jinan 1
Kilburn 1
Lianyun 1
Marseille 1
Modugno 1
Mumbai 1
New Bedfont 1
New Delhi 1
Paris 1
Pune 1
Sankt Augustin 1
Washington 1
Xian 1
Zhengzhou 1
Totale 1.043
Nome #
Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies 110
Evidence for bone marrow adult stem cell plasticity: Properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells transdifferentiation 108
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 107
Identify multiple myeloma stem cells: Utopia? 107
Multiple myeloma macrophages: Pivotal players in the tumor microenvironment 105
null 101
Neutropenia and G-CSF in lymphoproliferative diseases 99
Pharmacological activation of protein phosphatase 2 A (PP2A): A novel strategy to fight against human malignancies? 94
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma 75
High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma 72
A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents 64
Novel agents and new therapeutic approaches for treatment of multiple myeloma 58
Efficacy of filgrastim, lenograstim and peg-filgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative disorders. 51
Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma 39
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma 38
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 10
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 7
The bone marrow microenvironment in multiple myeloma: Cellular and molecular basis of disease progression 5
Vascular endothelial growth factor and its receprtors in multiple myeloma 3
Multiple Myeloma: Risk Factors, Diagnosis and Treatments 3
Clinical and experimental evidences of anti-myeloma activities of zolendronic acid 3
Totale 1.259
Categoria #
all - tutte 4.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.776


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020304 0 11 19 28 33 34 42 39 43 18 19 18
2020/2021189 5 15 15 13 21 9 13 15 3 24 32 24
2021/2022142 16 20 0 8 9 8 18 9 2 9 15 28
2022/2023242 25 47 14 25 14 41 2 29 37 1 4 3
2023/2024104 13 17 4 5 12 18 3 3 2 6 5 16
2024/202530 13 17 0 0 0 0 0 0 0 0 0 0
Totale 1.259